Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy

Cellular Physiology and Biochemistry

Volumn 26, Issue 3, 2010, Pages 383-394

  Bell, David ^a   Campbell, Malcolm ^a   Wang, Xuanhui ^a   Earle, J A Philip ^a   Cosby, S Louise ^a   McDermott, Barbara J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Adenoviral vectors; Adrenomedullin; Cardiomyocytes; Hypertrophy; Myocardial ischemia; Nitric oxide; Oxidative stress; Ventricular

Indexed keywords

ADENOVIRUS VECTOR; ADRENOMEDULLIN; ALPHA ACTIN; COMPLEMENTARY DNA; CYTOMEGALOVIRUS VECTOR; MEMBRANE PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART PROTECTION; IN VIVO STUDY; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSGENE;

ADENOVIRIDAE; CYTOMEGALOVIRUS; RATTUS;

EID: 78650010358     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320562     Document Type: Article

References (57)

1. Jacobson SL, Piper HM: Cell cultures of adult cardiomyocytes as models of the myocardium. J Mol Cell Cardiol 1986;18:439-448.
2. Schluter KD, Millar BC, McDermott BJ, Piper HM: Regulation of protein turnover in adult ventricular cardiomyocytes. Am J Physiol 1995;38:C1347-1355.
3. Dubus I, Rappaport L, Barrieux A, Lompre AM, Schwartz K, Samuel JL: Contractile protein gene expression in serum-free cultured adult rat cardiac myocytes. Pflugers Arch 1993;423:455-461.
4. McDonaugh PM, Brown JH, Glembolshi CC: Phenylephrine and endothelin-1 differentially stimulate cardiac PI hydrolysis and ANF expression. Am J Physiol 1993;264:H625-630.
5. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, Sawyer DB, Colucci WS: Inhibition of CuZn-SOD induces cell growth, hypertrophic phenotype and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999;85:147-153.
6. Stadtman ER: Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal catalysed reactions. Ann Rev Biochem 1993;62:797-802.
7. Hess ML and Manson NH: The oxygen free radical system and myocardial dysfunction. Adv Myocardiol 1985;5:177-181.
8. Stauss HM, Godecke A, Mrowka R, Schrader J: Enhanced blood pressure variability in eNOS gene knockout mice. Hypertension 1999;33:1359-1363.
9. Nonami Y, Rao V, Shiono N, Ogoshi S: Quenching the effects of L-arginine on free radical injury in cultured cardiomyocytes. Surgery Today 1998;28:379-384.
10. Matsuoka H, Nakata M, Kohno K: Chronic L-arginine administration attenuates cardiac hypertrophy in SHR. Hypertension 1996;27:14-18.
11. Hua L, Li C, Xia D, Qu P, Li Z, Zhang W, Feng X: Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertension Res 2001;23:377-380.
12. Bernatova I, Pechanova O, Simko F: Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exper Physiol 1999;84:1095-1105.
13. Bell D, Zhao Y Y, Kelso EJ, McHenry EM, Rush LM, Nicholls DP, McDermott BJ: Up-regulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis. Am J Physiol 2006;290:H904-H914.
14. Zhao YY, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ: Differential effects of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. JPET 2006;316:1269-1281.
15. Bell D, Zhao YY, McCoy FGP, Devine AB, McDermott BJ: Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency. Cell Physiol Biochem 2007;20:269-282.
16. Bell D, Zhao Y Y, Devine AB, McDermott BJ: Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components. Cell Physiol Biochem 2007;20:203-214.
17. Nakamura M, Yoshida H, Makita S: Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Circulation 1997;95:1214-1221.
18. Rademaker MT, Charles CJ, Lewis LK: Beneficial haemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 1997;96:1983-1989.
19. Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H, Kangawa K: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997;30:741-745.
20. Willenbrock R, Langenickel T, Knecht M: Regulation of cardiac adrenomedullin mRNA in different stages of experimental heart failure. Life Sci 1999;65:2241-2249.
21. Nishikimi T., Matsuoka H, Ishikawa K, Yoshihara F, Kawano Y, Kitamura K, Saito Y, Kangawa K, Matsuo H, Omae T: Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. Hypertens Res 1996;19:97-101.
22. Nagaya N, Nishikimi T, Yoshihara F, Horio T, Morimoto A, Kangawa K: Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol 2000;278:R1019-R1026.
23. Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, Dohi K, Kangawa K: Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension 1999;33:1146-52.
24. Sato A, Canny BJ, Autelitano DJ: Adrenomedullin stimulates cyclic AMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun 1997;230:311-314.
25. Pan CS, Yang JH, Cai DY, Zhao J, Gerns H, Yang J, Chang JW, Tang CS, Qi YF: Cardiovascular effects of newly discovered peptide intermedin / adrenomedullin-2. Peptides 2005;26:1640-1646.
26. Horio T, Nishikimi T, Yoshihara F, Nagaya N, Matsuo H, Takishita S, Kangawa K: Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1β and tumour necrosis factor-α. Endocrinology 1998;139:4576-4580.
27. Tsurada T, Kato J, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Komuro I, Yazaki Y, Eto T: Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes. Hypertension 2000;35:1210-1214.
28. Nishikimi T, Horio T, Yoshihara F, Nagaya N, Matsuo H, Kangawa K: Effect of adrenomedullin on cyclic AMP and cyclic GMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 1998;353:337-344.
29. Yang JH, Qi YF, Jia YX, Pan CS, Zhao J, Yang J, Chang JW, Tang C: Protective effects of intermedin/adrenomedullin-2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 2005;26:501-507. (Pubitemid 40126705)
30. Chao J, Kato K, Zhang JJ, Dobrzyski E, Wang C, Agata J, Chao L: Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides 2001;22:1731-1737.
31. Chao J, Jin L, Lin KF, Chao L: Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens Res 1997;20:269-277.
32. Dobrzynski E, Wang C, Chao J, Chao L: Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000;36:995-1001.
33. Wang C, Dobrzynski E, Chao J, Chao L: Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am J Physiol 2001;280:F964-F971.
34. Zhang JJ, Yoshida H, Chao L, Chao J: Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis and renal damage in hypertensive Dahl salt-sensitive rats. Hum Gene Ther 2000;11:1817-1827.
35. Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J: Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis and ischemia and reperfusion. Am J Physiol 2003;285:H1506-H1514.
36. Hayakawa H, Hirata Y, Kakoki M, Suzuki Y: Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 1999;33:689-693.
37. Shimekake Y, Nagata K, Ohta S, Kambayashi Y: Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and calcium mobilization in bovine aortic endothelial cells. J Biol Chem 1995;270:4412-4417.
38. He T, Zhou S, Dacosta LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-2514.
39. Karpinski BA, Yang LH, Cacheris P, Morle GD, Leiden JM: The first intron of the 4F2 heavy chain gene contains a transcription enhancer element that binds multiple nuclear proteins. Mol Cell Biol 1989;9:2588-2597.
40. Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K: Insertion of the adenoviral E3 region into a recombinant viral vector prevents anti-viral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci USA 1997:94:2587-2592.
41. Mizuguchi H, Kay MA: Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998;9:2577-2583.
42. Wang Q, Greenberg G, Bunch D, Farson D, Finer MH: Persistent transgene expression in mouse liver following in vivo gene transfer with dE1/dE4 adenovirus vector. Gene Ther 1997;4:393-400.
43. Becker TC, Noel RJ, Coates WS, Gomez-Fois AM, Alam T, Gerard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods in Cell Biol 1994;43:161-189.
44. Hardt SE, Sadoshima J: Negative regulators of cardiac hypertrophy. Cardiovasc Res 2004;63:500-509.
45. Brain SD, Grant AD: Vascular actions of CGRP and adrenomedullin. Physiol Res 2004;84:903-934.
46. Khan AI, Kato J, Ishiyama Y, Kitamura K, Kangawa K, Eto T: Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats. Eur J Pharmacol 1997;333:187-190.
47. Khan AI, Kato J, Kitamura K, Kangawa K, Eto T: Hypotensive effect of chronically infused adrenomedullin in Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1997;24:139-142. (Pubitemid 27142203)
48. Lang MG, Paterno R, Faraci FM, Heistad DD: Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 1997;28:181-185.
49. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N: Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001;104:1964-1971.
50. Shindo T, Kurihara H, Maemura K, Kurihara Y: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice over-expressing adrenomedullin in their vasculature. Circulation 2000;101:2309-2316.
51. Yang JH, Pan CS, Jia YX, Zhang J, Zhao J, Pang YZ, Yang J, Tang CS, Qi YF: Intermedin 1-53 activates L-arginine / nitric oxide synthase/nitric oxide pathway in rat aortas. Biochem Biophys Res Commun 2006;341:567-572.
52. Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, Bell W, Zhang H, Reckelhoff JF: Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol 2005;288:R903-R908.
53. Sainz J, Wangensteen R, Rodriguez Gomez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F: Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens 2005;18:871-877.
54. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM: International Union of Pharmacology XXXII: the mammalian calcitonin gene-related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev 2002;54:233-246.
55. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NADPH oxidase and endothelial nitric oxide synthase. Circulation 2002;105:1656-1662.
56. Tokudome T, Horio T, Yoshihara F, Suga S, Kawano Y, Kphno M, Kangawa K: Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinology 2002;143:3515-3521.
57. Pan CS, Jiang W, Zhon GZ, Zhao J, Pan YZ, Tang CS, Qi YF: Hypertension induced by nitric oxide synthase inhibitor increases responsiveness of ventricular myocardium and aorta of rat tissue to adrenomedullin stimulation in vitro. Life Sci 2005;78:398-405.